Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Outlook Therapeutics Inc. buy melinda

Start price
€1.21
02.12.21 / 50%
Target price
€2.00
02.12.22
Performance (%)
-17.22%
End price
€1.00
03.12.22
Summary
This prediction ended on 03.12.22 with a price of €1.00. The price of Outlook Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.22%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Outlook Therapeutics Inc. - - -
iShares Core DAX® 2.149% 5.415% 21.385%
iShares Nasdaq 100 0.838% 1.926% 44.386%
iShares Nikkei 225® 1.143% 2.887% 27.641%
iShares S&P 500 1.265% 3.698% 33.327%

According to melinda what are the pros and cons of Outlook Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Outlook Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -17.22%
Target price 2.000
Change
Ends at

Buy mit Kursziel 2,0

In the thread Trading Outlook Therapeutics Inc.
Prediction Buy
Perf. (%) -17.22%
Target price 2.000
Change
Ends at 02.12.22

Die von melinda gewählte maximale Laufzeit wurde überschritten

Stopped prediction by melinda for Outlook Therapeutics Inc.

buy
Outlook Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.24
29.08.23
€1.50
29.08.24
-68.71%
10.12.23

Could be worthwhile Investment >10% per year
buy
Outlook Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.58
27.09.20
€0.89
04.11.21
206.09%
05.11.21

Could be worthwhile Investment >10% per year